Skip to main content
SpringerLink
Log in

Drug Metabolism by the Gastrointestinal Mucosa

  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Abstract

Circumstantial evidence for first-pass metabolism across the gastrointestinal mucosa includes reduced bioavailability after oral administration, despite complete or good absorption. There may also be route-dependent variation in the pattern of metabolism with the latter occurring to a greater extent after oral administration than after parenteral injection. However, direct proof that first-pass metabolism takes place across the gastrointestinal mucosa relies upon cannulation of either the portal or mesenteric venous tree. Such studies are not possible in most patients because of the potential hazards involved and the attendant ethical considerations. Additional information has come from the study of enzyme activity in biopsies of intestinal mucosa and experiments performed on isolated loops of intestine in various animal species. Although the former have identified the fact that enzyme activity may vary along the length of the intestine and the latter have provided quantitative information on what can occur in vivo, these data cannot be extrapolated to intact man.

Both phase I (preconjugation) and phase II (conjugation) reactions have been described. However, except for oxidative deamination, e.g. tyramine and hydrolysis of esters such as pivampicillin and aspirin, phase I reactions appear to be quantitatively unimportant. In contrast, synthetic reactions are much more active. Sulphate conjugation, in particular, is important for the β-adrenoceptor stimulants isoprenaline (isoproterenol), isoetharine and rimiterol, as well as for steroid hormones. Glucuronidation has also been demonstrated to occur in man for a small number of drugs. N-Acetylation is an important pathway and, as in the liver, there is evidence of polymorphism. Metabolism of hydralazine, isoniazid, p-aminosalicylic acid as well as certain sulphonamides by intestinal N-acetyl transferase has been demonstrated, but in all probability affects other drugs as well.

Little is known concerning the physiological factors which alter the activity of the gastrointestinal drug-metabolising enzymes. However, significant drug-drug interactions have been demonstrated to occur at this site — particularly for drugs which undergo sulphate conjugation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Allen, J.G.; Atherton, F.R.; Hall, M.J.; Hassall, Ch.; Holmes, S.W.; Lambert, R.W.; Nisbet, L.J. and Ringrose, P.S.: Phosphonopeptides, a new class of synthetic antibacterial agents. Nature 272: 56–58 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Back, D.J.; Bates, M.; Breckenridge, A.M.; Crawford, F.E.; Ellis, A.; Hall, J.M.; MacIver, M.; Orme, M. L’E. and Rowe, P.H.: The in vitro metabolism of ethinyloestradiol, levonorgestrel and mestranol by human jejunal mucosa. British Journal of Clinical Pharmacology 9: 281–282P (1980).

    Article  Google Scholar 

  • Back, D.J.; Breckenridge, A.M.; Crawford, F.E.; MacIver, M.; Orme, M. L’E.; Rowe, P.H. and Watts, M.J.: An investigation of the pharmacokinetics of ethinyloestradiol in women using radioimmunoassay. Contraception 20: 263–273 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Back, D.J.; Bates, M.; Breckenridge, A.M.; Crawford, F.; Ellis, A.; Hall, J.M.; MacIver, M.; Orme, M.L’E.; Taylor, I. and Rovve, P.H.: Drug metabolism by gastrointestinal mucosa: Clinical aspects; in Prescott and Nimmo (Eds) Drug Absorption, pp.80–87 (ADIS, Sydney 1981).

    Google Scholar 

  • Barr, W.H. and Riegelman, S.: Intestinal drug absorption and metabolism. 1: Comparison of methods and models to study physiological factors of in vitro and in vivo intestinal absorption. Journal of Pharmaceutical Sciences 59: 154–163 (1970a).

    Article  PubMed  CAS  Google Scholar 

  • Barr, W.H. and Riegelman, S.: Intestinal drug absorption and metabolism. II: Kinetic aspects of intestinal glucuronide conjugation. Journal of Pharmaceutical Sciences 59: 164–168 (1970b).

    Article  PubMed  CAS  Google Scholar 

  • Bateman, D.N.; Kahn, C. and Davies, D.S.: The pharmacokinetics of metoclopramide in man with observations in the dog. British Journal of Clinical Pharmacology 9: 371–378 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Bennett, P.N.; Blackwell, E.W. and Davies, D.S.: Competition for sulphate during detoxification in the gut. Nature 258: 247–248 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Blondheim, S.H. and Kunkel, H.G.: Portal blood in collateral veins of patients with cirrhosis. Acetylation by the intestine. Proceedings of the Society for Experimental Biology and Medicine 73: 38–41 (1950).

    PubMed  CAS  Google Scholar 

  • Boström, H.; Brömster, D.; Nordenstam, H. and Wengle, B.: On the occurrence of phenol and steroid sulphokinases in the human gastrointestinal tract. Scandinavian Journal of Gastroenterology 3: 369–375 (1968).

    Article  PubMed  Google Scholar 

  • Brittain, R.T.: A comparison of the pharmacology of salbutamol with that of isoprenaline, orciprenaline and trimetoquinol. Postgraduate Medical Journal 47 (Suppl.): 11–16 (1971).

    PubMed  CAS  Google Scholar 

  • Brunk, S.F. and Delle, M.: Morphine metabolism in man. Clinical Pharmacology and Therapeutics 16: 51–57 (1974).

    PubMed  CAS  Google Scholar 

  • Buhs, R.P.; Beck, J.L.; Speth, O.C.; Smith, J.L.; Trenner, N.R.; Cannon, P.J. and Laragh, J.H.: The metabolism of methyldopa in hypertensive human subjects. Journal of Pharmacology and Experimental Therapeutics 143: 205–214 (1964).

    PubMed  CAS  Google Scholar 

  • Caldwell, J.: The metabolism of drugs by the gastrointestinal tract; in George et al. (Eds) Presystemic Drug Elimination (Butterworths, London, in press 1981).

  • Christophersen, E.B. and Jackson, F.C.: A technique of trans-umbilical portal vein catheterisation in adults. Archives of Surgery 95: 960–963 (1967).

    Article  PubMed  CAS  Google Scholar 

  • Conney, A.H.; Pantuck, E.J.; Hsiao, K-C.; Garland, W.A.; Anderson, K.E.; Alvarez, A.P. and Kappas, A.: Enhanced phenacetin metabolism in human subjects fed charcoal-broiled beef. Clinical Pharmacology and Therapeutics 20: 633–642 (1976).

    PubMed  CAS  Google Scholar 

  • Conolly, M.E.; Davies, D.S.; Dollery, C.T.; Morgan, C.D.; Paterson, J.W. and Sandler, M.: Metabolism of isoprenaline in dog and man. British Journal of Pharmacology 46: 458–472 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Cotler, S.; Holazo, A.; Boxenbaum, H.G. and Kaplan, S.A.: Influence of route of administration on physiological availability of levodopa in dogs. Journal of Pharmaceutical Sciences 65: 822–827 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Coutinho, C.B.; Spiegel, H.E.; Kaplan, S.A.; Yu, M.; Christian, R.P.; Carbone, J.J.; Symington, J.; Cheripko, J.A.; Lewis, M.; Tonchen, A. and Crews, T.: Kinetics of absorption and excretion of levodopa in dogs. Journal of Pharmaceutical Sciences 60: 1014–1019 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Curry, S.H.; D’Mello, A. and Mould, G.P.: Destruction of chlorpromazine during absorption in the rat in vivo and in vitro. British Journal of Pharmacology 42: 403–411 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Dahl, S.G. and Strandjord, R.E.: Pharmacokinetics of chlorpromazine after single and chronic dosage. Clinical Pharmacology and Therapeutics 21: 437–448 (1977).

    PubMed  CAS  Google Scholar 

  • Das, K.M. and Dubin, R.: Clinical pharmacokinetics of sulphasalazine. Clinical Pharmacokinetics 1: 406–425 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Davies, D.S.; George, C.F.; Blackwell, E.W.; Conolly, M.E. and Dollery, C.T.: Metabolism of terbutaline in man and dog. British Journal of Clinical Pharmacology 1: 129–136 (1974).

    Article  PubMed  Google Scholar 

  • Davies, D.S.; Ilett, K.F. and George, C.F.: Drug metabolism by intestinal mucosa. Clinical Pharmacokinetics. In press (1980).

  • Dencker, H.; Dencker, S.J.; Green, A. and Nagy, A.: Intestinal absorption, demethylation and enterohepatic circulation of imipramine. Clinical Pharmacology and Therapeutics 19: 584–586 (1976).

    PubMed  CAS  Google Scholar 

  • Diamond, M.A.; Murray, R.H. and Schmid, P.G.: Idiopathic postural hypotension: Physiologic observations and report of a new mode of therapy. Journal of Clinical Investigation 49: 1341–1348 (1970).

    Article  PubMed  CAS  Google Scholar 

  • Diczfalusy, E.; Franksson, C.; Lisboa, B.P. and Martinsen, B.: Formation of estrone glucosiduronate by the human intestinal tract. Acta Endocrinologica 40: 537–551 (1962).

    PubMed  CAS  Google Scholar 

  • Diczfalusy, E.; Franksson, C. and Martinsen, B.: Oestrogen conjugation by the human intestinal tract. Acta Endocrinologica 38: 59–72 (1961).

    PubMed  CAS  Google Scholar 

  • Dollery, C.T.; George, C.F. and Orme, M.L’E.: Drug interactions affecting cardiovascular therapy; in Cluff and Petrie (Eds) Clinical Effects of Interaction between Drugs, pp.117–151 (Excerpta Medica, Amsterdam 1974).

    Google Scholar 

  • Evans, M.E.; Shenfield, G.M.; Thomas, N.; Walker, S.R. and Paterson, J.W.: The pharmacokinetics of rimiterol in man. Xenobiotica 4: 681–692 (1974).

    Article  CAS  Google Scholar 

  • Evans, M.E.; Walker, S.R.; Brittain, R.T. and Paterson, J.W: The metabolism of salbutamol in man. Xenobiotica 3: 113–120 (1973).

    Article  PubMed  CAS  Google Scholar 

  • George, C.F.: Drug kinetics and hepatic blood flow. Clinical Pharmacokinetics 4: 433–448 (1979).

    Article  PubMed  CAS  Google Scholar 

  • George, C.F.; Blackwell, E.W. and Davies, D.S.: Metabolism of isoprenaline in the intestine. Journal of Pharmacy and Pharmacology 26: 265–267 (1974).

    Article  PubMed  CAS  Google Scholar 

  • George, C.F.; Higgins, V.; Power, K.J.; Renwick, A.G. and Smith, C.L.: Pharmacokinetics of methyldopa in gastrointestinal disease. British Journal of Clinical Pharmacology 9: 109–110P (1980).

    Article  Google Scholar 

  • George, C.F.; Orme, M.L’E.; Buranapong, P.; Macerlean, D.; Breckenridge, A.M. and Dollery, C.T.: Contribution of the liver to overall elimination of propranolol. Journal of Pharmacokinetics and Biopharmaceutics 4: 17–27 (1976).

    PubMed  CAS  Google Scholar 

  • Goldin, B.R. and Goldman, P.: The metabolism of dopa: The role of the intestinal microflora. Federation Proceedings 32: 798 (1973).

    Google Scholar 

  • Harris, P.A. and Riegelman, S.: Influence of the route of administration on the area under the plasma concentration-time curve. Journal of Pharmaceutical Sciences 58: 71–75 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Hartiala, K.: Metabolism of hormones, drugs and other substances by the gut. Physiological Reviews 53: 496–534 (1973).

    PubMed  CAS  Google Scholar 

  • Hayes, A. and Cooper, R.G.: Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey. Journal of Pharmacology and Experimental Therapeutics 176: 302–311 (1971).

    PubMed  CAS  Google Scholar 

  • Hinderung, P.H.; Garrett, E.R. and Webster, R.C.: Pharmacokinetics of β-methyl digoxin in healthy humans. I. Intravenous studies. Journal of Pharmaceutical Sciences 66: 242–253 (1977a).

    Article  Google Scholar 

  • Hinderung, P.H.; Garrett, E.R. and Webster, R.C.: Pharmacokinetics of β-methyl digoxin in healthy humans II. Oral studies and bioavailability. Journal of Pharmaceutical Sciences 66: 314–325 (1977b).

    Article  Google Scholar 

  • Hollister, L.E. and Curry, S.H.: Urinary excretion of chlorpromazine metabolites following single doses and in steady state conditions. Research Communications in Chemical Pathology and Pharmacology 2: 330–338 (1971).

    PubMed  CAS  Google Scholar 

  • Hollister, L.E.; Curry, S.H.; Derr, J.E. and Kanter, S.L.: Studies of delayed-action medications. V. Plasma levels and urinary excretion of four different dosage forms of chlorpromazine. Clinical Pharmacology and Therapeutics 11: 49–59 (1970).

    PubMed  CAS  Google Scholar 

  • Holzbauer, M. and Youdim, M.B.H.: The oestrous cycle and monoamine oxidase activity. British Journal of Pharmacology 48: 600–608 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Humpel, M.; Wendt, H.; Pommerenke, G., Weib, Chr. and Speck, U.: Investigations of pharmacokinetics of levonorgestrel to specific consideration of a possible first-pass effect in women. Contraception 17: 207–220 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Ilett, K.F.; Dollery, C.T. and Davies, D.S.: Isoprenaline conjugation — a ‘true first-pass effect’ in the dog intestine. Journal of Pharmacy and Pharmacology 32: 362 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Ilett, K.F.; George, C.F. and Davies, D.S.: The effect of monoamine oxidase inhibitors on ‘first-pass’ metabolism of tyramine in dog intestine. Biochemical Pharmacology 29: 2551–2556 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Iwamoto, K. and Klassen, C.D.: First-pass effect of morphine in rats. Journal of Pharmacology and Experimental Therapeutics 200: 236–244 (1977a).

    PubMed  CAS  Google Scholar 

  • Iwamoto, K. and Klassen, C.D.: First-pass effect of nalorphine in rats. Journal of Pharmacology and Experimental Therapeutics 203: 365–376 (1977b).

    PubMed  CAS  Google Scholar 

  • Jenne, J.W.: Isoniazid acetylation by human liver and intestinal mucosa. Federation Proceedings 22: 540 (1963).

    Google Scholar 

  • Jenne, J.W.: Partial purification and properties of the isoniazid transacetylase in human liver. Its relationship to the acetylation of p-aminosalicylic acid. Journal of Clinical Investigation 44: 1992–2002 (1965).

    Article  CAS  Google Scholar 

  • Karim, A.: Spironolactone: Disposition, metabolism, pharmacodynamics and bioavailability. Drug Metabolism Reviews 8: 151–188 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Kwan, K.C.; Foltz, E.L.; Breault, C.O.; Baer, J.E. and Totaro, J.A.: Pharmacokinetics of methyldopa in man. Journal of Pharmacology and Experimental Therapeutics 198: 264–277 (1976).

    PubMed  CAS  Google Scholar 

  • Leigh, D.A.; Reeves, D.S.; Simmons, K.; Thomas, A.L. and Wilkinson, P.J.: Talampicillin: A new derivative of ampicillin. British Medical Journal 1: 1378–1380 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Levine, R.J. and Sjoerdsma, A.: Estimation of monoamine oxidase activity in man: Techniques and applications. Annals of the New York Academy of Sciences 107: 966–974 (1963).

    Article  PubMed  CAS  Google Scholar 

  • Levy, G. and Matsuzawa, T.: Pharmacokinetics of salicylamide elimination in man. Journal of Pharmacology and Experimental Therapeutics 156: 285–293 (1967).

    PubMed  CAS  Google Scholar 

  • Lund, B.; Kampmann, J.P.; Lindahl, F. and Hansen, J.M.: Pivampicillin and ampicillin in bile, portal and peripheral blood. Clinical Pharmacology and Therapeutics 19: 587–591 (1976).

    PubMed  CAS  Google Scholar 

  • Mahon, W.A.; Inaba, T. and Stone, R.M.: Metabolism of flurazepam by the small intestine. Clinical Pharmacology and Therapeutics 22: 228–233 (1977).

    PubMed  CAS  Google Scholar 

  • Mandelli, M.; Tognoni, G. and Garattini, S.: Clinical pharmacokinetics of diazepam. Clinical Pharmacokinetics 3: 72–91 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Mearrick, P.T.; Wade, D.N.; Birkett, D.J. and Morris, J.: Metoclopramide, gastric emptying and 1-dopa absorption. Australian and New Zealand Journal of Medicine 4: 144 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Melander, A.: Influence of food on the bioavailability of drugs. Clinical Pharmacokinetics 3: 337–351 (1978).

    Article  PubMed  CAS  Google Scholar 

  • Pantuck, E.J.; Hsiao, K.-C.; Kaplan, S.A.; Kuntzman, R. and Conney, A.H.: Effects of enzyme induction on intestinal phenacetin metabolism in the rat. Journal of Pharmacology and Experimental Therapeutics 191: 45–52 (1974).

    PubMed  CAS  Google Scholar 

  • Pantuck, E.J.; Hsiao, K.C.; Kuntzman, R. and Conney, A.H.: Intestinal metabolism of phenacetin in the rat: effect of charcoal-broiled beef and rat chow. Science 187: 744–746 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Prescott, L.F.; Buhs, R.P.; Beattie, J.O.; Speth, O.C.; Trenner, N.R. and Lasagna, L.: Combined clinical and metabolic study of the effects of alphamethyldopa on hypertensive patients. Circulation 34: 308–321 (1966).

    Article  PubMed  CAS  Google Scholar 

  • Rance, M.J. and Shillingford, S.S.: The metabolism of phenolic opiates by rat intestine. Xenobiotica 7: 529–536 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Redwood, D.: Conservative treatment of chronic heart block. British Medical Journal 1: 26–29 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Reid, J.L.; Calne, D.B.; George, C.F. and Vakil, S.D.: The action of L(−)dopa on baroreflexes in Parkinsonism. Clinical Science 43: 851–859 (1972).

    PubMed  CAS  Google Scholar 

  • Rivera Calimlim, L.; Dujovne, C.A.; Morgan. J.P.; Lasagna, L. and Bianchine, J.R.: Absorption and metabolism of L-Dopa by the human stomach. European Journal of Clinical Investigation 1: 313–320 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Rivera-Calimlim, L.; Morgan, J.P.; Dujovne, C.A.; Bianchine, J.R. and Lasagna, L.: L-3,4-dihydroxyphenyalanine metabolism by the gut in vitro. Biochemical Pharmacology 20: 3051–3057 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Routledge, P.A. and Shand, D.G.: Presystemic drug elimination. Annual Review of Pharmacology and Toxicology 19: 447–468 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Rowland, M.; Riegelman, S.; Harris, P.A.; Sholkoff, S.D. and Eyring, E.J.: Kinetics of acetylsalicylic acid disposition in man. Nature 215: 413–414 (1967).

    Article  PubMed  CAS  Google Scholar 

  • Sandler, M.; Goodwin, B.C.; Ruthven, C.R.J. and Calne, D.B.: Therapeutic implications in Parkinsonism of m-Tyramine formation from L-dopa in man. Nature 229: 414–416 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Sandler, M.; Karoum, F.; Ruthven, C.R.J. and Calne, D.B.: m-Hydroxy phenylacetic acid formation from L-dopa in man: Suppression by neomycin. Science 166: 1417–1418 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Sandler, M.; Ruthven, C.R.J.; Goodwin, B.L.; Hunter, K.R. and Stern, G.M.: Variation of levodopa metabolism with gastrointestinal absorption site. Lancet 1: 238–239 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Sjoerdsma, A.; Vendsalu, A. and Engelman, K.: Studies on the metabolism and mechanism of action of methyldopa. Circulation 28: 492–502 (1963).

    Article  PubMed  CAS  Google Scholar 

  • Southgate, J.; Grant, E.C.G.; Pollard, W.; Pryse-Davies, J. and Sandler, M.: Cyclical variations in endometrial monoamine oxidase: Correlation of histochemical and quantitative biochemical assays. Biochemical Pharmacology 17: 721–726 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Spencer, R.P.; Brody, K.R. and Lutters, B.M.: Some effects of ethanol on the gastrointestinal tract. American Journal of Digestive Diseases 9: 599–604 (1964).

    Article  PubMed  CAS  Google Scholar 

  • Talseth, T.: Studies on hydralazine. III. Bioavailability of hydralazine in man. European Journal of Clinical Pharmacology 10: 395–401 (1976).

    Article  PubMed  CAS  Google Scholar 

  • Talseth, T.: Clinical pharmacokinetics of hydrallazine. Clinical Pharmacokinetics 2: 317–329 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Wattenberg, L.W.; Leong, J.L. and Strand, P.J.: Benzpyrene hydroxylase activity in the gastrointestinal tract. Cancer Research 22: 1120–1125 (1962).

    PubMed  CAS  Google Scholar 

  • Weber, W.W. and Hein, D.W.: Clinical pharmacokinetics of isoniazid. Clinical Pharmacokinetics 4: 401–422 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Williams, F.M.; Briant, R.H.; Dollery, C.T. and Davies, D.S.: The influence of the route of administration on urinary metabolites of isoetharine. Xenobiotica 4: 345–353 (1974).

    Article  PubMed  CAS  Google Scholar 

  • Youdim, M.B.H.; Woods, H.F.; Mitchell, B.; Grahame-Smith, D.G. and Calender, S.: Human platelet monoamine oxidase activity in iron-deficiency anaemia. Clinical Science and Molecular Medicine 48: 289–295 (1975).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Pharmacology Group, University of Southampton, Medical and Biological Sciences Building, Bassett Crescent East, Southampton, SO9 3TU, England

    Charles F. George

Authors
  1. Charles F. George
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

George, C.F. Drug Metabolism by the Gastrointestinal Mucosa. Clin Pharmacokinet 6, 259–274 (1981). https://doi.org/10.2165/00003088-198106040-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198106040-00002

Keywords

Search

Navigation